Labscape Maintenance Service Agreements

Microbiology & Diagnostics

Maintenance Service Agreements

Service agreements

Bruker LabScape maintenance service agreements are a key component for maximizing the duty cycle and reliability of your instrument. This leads to a significant increase in productivity while having complete cost control and maximum planning security. These flexible service solutions suit your needs and budget and include following options:

  • Modern remote support and diagnostics
  • Regular instrument maintenance
  • Unlimited on-site repairs
  • Original parts and supplies
  • Dedicated on-site training
  • Targeted application support
  • State-of-the art compliance services
  • Comprehensive software services

LabScape™ - Service & Lifecycle Support Brochure

Service Agreements

Choose one of the following LabScape Maintenance Service Agreements available for instruments used for microbiology and diagnostics:

LabScape Essential – Ensure peak performance. A combination of remote support and regular annual maintenance helps you operate your instrument under optimal conditions.

LabScape Complete – All support you need. A comprehensive solution providing
comprehensive service including spare, wear and tear parts which helps you avoid instrument failures, costly repairs and down time.

LabScape Complete 48 – All the support you need within 48 hours. A package including guaranteed on-site response within two business days to resolve the problem before it affects your business.

LabScape Complete 24 – High-availability services within 24 hours. A VIP package
for time-critical operations with all services and a guaranteed next-business-day on-site response.*


Remote Services LabScape
Complete 48
Complete 24
Unlimited Priority Remote Support
Augmented Reality – Virtual Engineer
Software services        
MBT Compass SW and Library Upgrades
Regular Maintenance        
Regular Maintenance Work and Parts
On-site Repair Services and Parts        
Unlimited Repair Visits incl. Spare Parts discount
Wear and Tear Part Replacement discount
Loaner Equipment*      
Compliance Services        
Operational Qualification / Performance. Validation      
On-site Response Service Level        
On-site Response   3-5 business
2nd business day next business day
Additional benefits        
Operation Training or Applications Training discount premium discount premium discount premium discount

* Not available at al l Bruker Locations.

Related Products



Customer information with regards to COVID-19

What your Bruker Microbiology & Diagnostics Team can do for you during the COVID-19 crisis - On-site service for your system, supply of CARE consumables and digital meetings

COVID-19/SARS-CoV-2 Testing

Identifying infection and differentiating from other respiratory diseases

Antimicrobial susceptibility testing

The MICRONAUT broth microdilution (BMD) product portfolio offers a broad range of antibiotic resistance and specialty antimicrobial susceptibility testing.

Microbial Identification (GP + RUO)

The MALDI Biotyper® is an automated next generation microbial identification system based on matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry, and has become the method of choice for routine identification in clinical microbiology laboratories worldwide.

Microbial Identification for Clinical Laboratories (IVD-CE)

Unbiased and fast identification of microorganisms down to the species level, revolutionizing the analysis of microorganisms

Microbial Identification for Clinical Laboratories (US-IVD)

A key task in clinical microbiology is unbiased and fast identification of microorganisms down to the species level.

Microbial Strain Typing

Fast, easy and cost-effective strain typing for effective hospital hygiene management and microbial quality control in food and beverage production.

Molecular Diagnostics

Molecular diagnostics significantly impacts patient care and laboratory management, with rapid real-time PCR.

Sepsis and resistance testing

The threat of multi-drug resistance (MDR) among gram-negative and gram-positive pathogens has increased worldwide over recent years, impacting both hospital and community acquired infections. Bruker is addressing the need for rapid and accurate solutions to achieve fast identification and resistance detection from Positive Blood Cultures (PBC).